Paper6209513
High-dose intravenous gammaglobulin for Kawasaki disease.
Furusho K and 9 others. Lancet, 1984. Cited by 679 papers, by iCite.
Cite this record
ConductScience Library. High-dose intravenous gammaglobulin for Kawasaki disease. Papers, record 6209513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6209513
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mucocutaneous Lymph Node Syndrome | Major topic |
| gamma-Globulins | Major topic |
| Acute Disease | |
| Administration, Oral | |
| Aspirin | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Coronary Disease | |
| Echocardiography | |
| Female | |
| Humans | |
| Infant | |
| Infusions, Parenteral | |
| Male | |
| Random Allocation |
Source PubMed
Cited by235
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 679 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964435 | Efficacy and Safety of Adjunctive Corticosteroids in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis of Randomized Trials. | Cardiol Res | 2026 | https://conductscience.org/library/papers/42964435 | PubMed |
| 42550508 | Epidemiology of Kawasaki Disease After the COVID-19 Pandemic in Japan 2023-2024. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42550508 | PubMed |
| 42511747 | The Autophagy-Inflammasome Axis as a Molecular Switch: From Persistent Inflammation to Vascular Remodeling in IVIG-Resistant Kawasaki Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511747 | PubMed |
| 42086942 | Evolving strategies and unresolved challenges in IVIG resistance prediction models for Kawasaki disease. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42086942 | PubMed |
| 41949774 | Predicting coronary artery abnormalities in Kawasaki disease: Model development and validation. | Eur J Pediatr | 2026 | https://conductscience.org/library/papers/41949774 | PubMed |
| 41762230 | Age-specific Association of Serum Albumin with Immunoglobulin Resistance and Coronary Artery Involvement in Kawasaki Disease. | Pediatr Cardiol | 2026 | https://conductscience.org/library/papers/41762230 | PubMed |
| 41670642 | Predicting the Need for Infliximab in Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide at Diagnosis. | Pediatr Cardiol | 2026 | https://conductscience.org/library/papers/41670642 | PubMed |
| 41649640 | Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease. | Curr Rheumatol Rep | 2026 | https://conductscience.org/library/papers/41649640 | PubMed |
| 41491167 | Incomplete Kawasaki disease associated with acute icteric hepatitis and Torque teno virus infection: a case report and literature review. | BMC Pediatr | 2026 | https://conductscience.org/library/papers/41491167 | PubMed |
| 41436876 | Early differentiation of Kawasaki disease preceded by cervical lymphadenopathy from bacterial cervical lymphadenitis. | Eur J Pediatr | 2025 | https://conductscience.org/library/papers/41436876 | PubMed |
| 41312550 | MFG-E8 in Kawasaki Disease: Role in Endothelial Injury and Diagnostic Potential. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41312550 | PubMed |
| 41018844 | Echocardiographic Evaluation in Kawasaki Disease. | J Med Ultrasound | 2025 | https://conductscience.org/library/papers/41018844 | PubMed |
| 40934829 | Impaired cardiopulmonary functions in prepubertal patients with Kawasaki disease. | Clinics (Sao Paulo) | 2025 | https://conductscience.org/library/papers/40934829 | PubMed |
| 40636515 | Delineation of single-cell Altas provides new insights for development of coronary artery lesions in Kawasaki disease: bad and good signaling molecules. | Front Pediatr | 2025 | https://conductscience.org/library/papers/40636515 | PubMed |
| 40635748 | Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40635748 | PubMed |
| 40221756 | A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China. | Ital J Pediatr | 2025 | https://conductscience.org/library/papers/40221756 | PubMed |
| 40084926 | Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling. | Immunol Rev | 2025 | https://conductscience.org/library/papers/40084926 | PubMed |
| 39941446 | Impact of a Concurrent Respiratory Virus Infection on the Clinical Presentation and Response to Initial Treatment of Kawasaki Disease: A Single-Center Observational Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/39941446 | PubMed |
| 39905354 | Assessment of sleep problems in patients with Kawasaki disease: a survey-based study. | BMC Pediatr | 2025 | https://conductscience.org/library/papers/39905354 | PubMed |
| 39808233 | Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesion involvement in Kawasaki disease: a retrospective study. | Clin Rheumatol | 2025 | https://conductscience.org/library/papers/39808233 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6209513
GET https://conductscience.org/api/papers/v1/6209513/cited_by?page=2